George W. Lloyd, CLO of Royalty Pharma RPRX, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $13.8M. The latest trade was on 25/12/18.

GL

GL

George W. Lloyd

EVP, Investments & CLO

Company

Royalty Pharma RPRX

First filing

23/02/27

Trades

29 trades

Buys / sales

0 / 18

12-month net buying

−$13.8M

Last trade

25/12/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Royalty PharmaRPRX	Open-market sale10b5-1 plan	25/12/17–25/12/18	25/12/19	110,000 sh2 trades	$38.55avg.	$4,240,554.22	−100.0%
Royalty PharmaRPRX	Open-market sale10b5-1 plan	25/12/03	25/12/05	110,000 sh	$39.77	$4,374,700	−50.0%
Royalty PharmaRPRX	Open-market sale10b5-1 plan	25/11/19	25/11/21	135,426 sh8 trades	$38.34avg.	$5,192,846.29	No record
Royalty PharmaRPRX	Open-market sale	23/06/02–23/06/06	23/06/06	192,221 sh4 trades	$33.71avg.	$6,479,384.37	−86.5%
Royalty PharmaRPRX	Open-market sale	23/03/28–23/03/29	23/03/30	112,779 sh2 trades	$37.06avg.	$4,179,206.37	−34.7%
Royalty PharmaRPRX	Open-market sale	23/02/23	23/02/27	25,000 sh	$37.27	$931,750	−7.1%